Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2019-11, Vol.94 (11), p.E305-E307
Hauptverfasser:	Galadanci, Aisha A., Galadanci, Najibah A., Jibir, Binta W., Abdullahi, Shehu U., Idris, Nura, Gambo, Safiya, Ali Abubakar, Shehi A., Kabo, Nasiru A., Bello‐Manga, Halima, Haliru, Lawal, Bashir, Ibrahim, Aliyu, Muktar H., Galadanci, Jamil A., DeBaun, Michael R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia, Sickle Cell - complications Anemia, Sickle Cell - drug therapy Anemia, Sickle Cell - epidemiology Antisickling Agents - therapeutic use Child Child, Preschool Female Hematology Humans Hydroxyurea Hydroxyurea - therapeutic use Infant Infant, Newborn Male Mass Screening - methods Mass Screening - organization & administration Nigeria - epidemiology Sickle cell disease Stroke - diagnostic imaging Stroke - epidemiology Stroke - etiology Stroke - prevention & control Ultrasonography, Doppler, Transcranial
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!